Cargando…
The Pentose Phosphate Pathway and Its Involvement in Cisplatin Resistance
Cisplatin is the first-line treatment for different types of solid tumors, such as ovarian, testicular, bladder, cervical, head and neck, lung, and esophageal cancers. The main problem related to its clinical use is the onset of drug resistance. In the last decades, among the studied molecular mecha...
Autores principales: | Giacomini, Isabella, Ragazzi, Eugenio, Pasut, Gianfranco, Montopoli, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036764/ https://www.ncbi.nlm.nih.gov/pubmed/32023830 http://dx.doi.org/10.3390/ijms21030937 |
Ejemplares similares
-
Mitochondrial Involvement in Cisplatin Resistance
por: Cocetta, Veronica, et al.
Publicado: (2019) -
Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells
por: Catanzaro, Daniela, et al.
Publicado: (2018) -
Regulation of the pentose phosphate pathway in cancer
por: Jiang, Peng, et al.
Publicado: (2014) -
Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death
por: Catanzaro, Daniela, et al.
Publicado: (2015) -
Pentose Phosphate Pathway Reactions in Photosynthesizing Cells
por: Sharkey, Thomas D.
Publicado: (2021)